ATE285177T1 - Thiole zur förderung des wachstumsvon hömatopoietischen vorläuferzellen - Google Patents

Thiole zur förderung des wachstumsvon hömatopoietischen vorläuferzellen

Info

Publication number
ATE285177T1
ATE285177T1 AT96906519T AT96906519T ATE285177T1 AT E285177 T1 ATE285177 T1 AT E285177T1 AT 96906519 T AT96906519 T AT 96906519T AT 96906519 T AT96906519 T AT 96906519T AT E285177 T1 ATE285177 T1 AT E285177T1
Authority
AT
Austria
Prior art keywords
growth
cells
progenicial
hometopoietic
thiole
Prior art date
Application number
AT96906519T
Other languages
English (en)
Inventor
Robert L Capizzi
Alan F List
Original Assignee
Medimmune Oncology Inc
Univ Arizona
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medimmune Oncology Inc, Univ Arizona filed Critical Medimmune Oncology Inc
Application granted granted Critical
Publication of ATE285177T1 publication Critical patent/ATE285177T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/145—Amines having sulfur, e.g. thiurams (>N—C(S)—S—C(S)—N< and >N—C(S)—S—S—C(S)—N<), Sulfinylamines (—N=SO), Sulfonylamines (—N=SO2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT96906519T 1995-02-17 1996-02-16 Thiole zur förderung des wachstumsvon hömatopoietischen vorläuferzellen ATE285177T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/390,713 US5846958A (en) 1995-02-17 1995-02-17 Methods of using aminothiols to promote hematopoietic progenitor cell growth
PCT/US1996/002188 WO1996025045A1 (en) 1995-02-17 1996-02-16 Thiols to promote hematopoietic progenitor cell growth

Publications (1)

Publication Number Publication Date
ATE285177T1 true ATE285177T1 (de) 2005-01-15

Family

ID=23543611

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96906519T ATE285177T1 (de) 1995-02-17 1996-02-16 Thiole zur förderung des wachstumsvon hömatopoietischen vorläuferzellen

Country Status (10)

Country Link
US (2) US5846958A (de)
EP (1) EP0809437B1 (de)
JP (1) JP4057648B2 (de)
AT (1) ATE285177T1 (de)
AU (1) AU694847B2 (de)
CA (1) CA2213322C (de)
DE (1) DE69634074T2 (de)
ES (1) ES2235183T3 (de)
PT (1) PT809437E (de)
WO (1) WO1996025045A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6573253B2 (en) 1997-02-12 2003-06-03 Medimmune Oncology Inc. Methods for the administration of amifostine and related compounds
US6051563A (en) * 1997-02-12 2000-04-18 U.S. Bioscience, Inc. Methods for the administration of amifostine and related compounds
US5994409A (en) * 1997-12-09 1999-11-30 U.S. Bioscience, Inc. Methods for treatment of neuro--and nephro--disorders and therapeutic toxicities using aminothiol compounds
US6953777B2 (en) * 1999-03-11 2005-10-11 Genetics Indtitute LLC Use of interleukin-11 to prevent immune-mediated cytotoxicity
US6489312B1 (en) * 1999-06-15 2002-12-03 Medimmune Oncology, Inc. Pharmaceutical formulations comprising aminoalkyl phosphorothioates
US7022315B2 (en) * 2000-04-26 2006-04-04 Oregon Health & Science University Administration of a thiol-based chemoprotectant compound
US7053072B2 (en) * 2001-05-11 2006-05-30 Medimmune Oncology, Inc. Methods for the administration of amifostine and related compounds
AU2002362088A1 (en) * 2001-12-06 2003-06-23 Catholic University Method and composition for inducing weight loss
US6982080B2 (en) * 2002-03-15 2006-01-03 Wyeth Hydroxyethyl starch—containing polypeptide compositions
AU2003296413A1 (en) * 2002-09-16 2004-04-30 Wyeth Delayed release formulations for oral administration of a polypeptide therapeutic agent and methods of using same
AU2003285128A1 (en) * 2002-10-31 2004-05-25 Oregon Health And Science University Use of thiol-based compositions in treating chemotherapeutic agent-induced thrombocytopenia
US20070148154A1 (en) * 2004-12-17 2007-06-28 Universite Rene Descartes (Paris V) Use of superoxide dismutase mimetics and reductase gultatione in the form of anticancer drugs
WO2007096901A1 (en) * 2006-02-24 2007-08-30 Natco Pharma Limited Novel dihydrate form of amifostine and process for its preparation
WO2012037283A2 (en) * 2010-09-14 2012-03-22 Mount Sinai School Of Medicine Admimistration of sns neuroprotective agents to promote hematopoietic regeration
CN108495625B (zh) 2015-11-17 2021-07-27 柏林顿Hc研究集团有限公司 改善对氨基硫醇及其类似物的保护和递送的方法
GB201706544D0 (en) * 2017-04-25 2017-06-07 Plasticell Ltd Method
JP7205473B2 (ja) 2017-07-28 2023-01-17 日産化学株式会社 培地添加用組成物及び培地添加用化合物並びにそれらを用いた細胞又は組織の培養方法
GB201817385D0 (en) * 2018-10-25 2018-12-12 Plasticell Ltd Therapy
EP3915636A4 (de) 2019-01-30 2022-03-09 Nissan Chemical Corporation Hydrazidverbindung und kinaseinhibitor
GB202303026D0 (en) 2023-03-01 2023-04-12 Plasticell Ltd Therapy

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3892824A (en) * 1968-12-16 1975-07-01 Southern Res Inst S-{107 -({107 -aminoalkylamino)alkyl dihydrogen phosphorothioates
US4656034A (en) * 1985-05-20 1987-04-07 Survival Technology, Inc. Absorption enhancing agents
EP0394542A1 (de) * 1989-04-25 1990-10-31 American Cyanamid Company Wiederherstellung der Knochenmarkszellen mit synthetischen CSF-Induktoren
WO1991005571A1 (en) * 1989-10-10 1991-05-02 University Of Rochester Method for producing bone marrow growth cell factors
PT100914A (pt) * 1991-09-30 1993-10-29 Jess G Thoene Uso de compostos capazes de sofrer uma permuta mista com dissulfureto, com uma ligacao dissulfureto, no tratamento de infeccao por hiv
US5824664A (en) * 1993-03-26 1998-10-20 U.S. Bioscience, Inc. Suppression of HIV expression by organic thiophosphate

Also Published As

Publication number Publication date
ES2235183T3 (es) 2005-07-01
DE69634074D1 (de) 2005-01-27
PT809437E (pt) 2005-05-31
JPH11504000A (ja) 1999-04-06
CA2213322C (en) 2008-05-13
US5846958A (en) 1998-12-08
US5906984A (en) 1999-05-25
AU4986996A (en) 1996-09-04
EP0809437A1 (de) 1997-12-03
CA2213322A1 (en) 1996-08-22
EP0809437A4 (de) 2001-05-09
EP0809437B1 (de) 2004-12-22
AU694847B2 (en) 1998-07-30
MX9706255A (es) 1998-08-30
JP4057648B2 (ja) 2008-03-05
WO1996025045A1 (en) 1996-08-22
DE69634074T2 (de) 2006-01-19

Similar Documents

Publication Publication Date Title
ATE285177T1 (de) Thiole zur förderung des wachstumsvon hömatopoietischen vorläuferzellen
ATE116848T1 (de) Verwendung von baclofen zur herstellung von arzneimitteln zur behandlung von angina pectoris.
HUT75776A (en) Pyrazolo and pyrrolopyridines, their using, pharmaceutical compositions containing them and intermediates
ES2114786A1 (es) Tromboyetina. trombopoyetina recombinante y procedimiento de obtencion.
ATE237633T1 (de) Analogen des keratinozytenwachstumfaktors
DE69004081D1 (de) Verwendung der Stearidonsäure zur Behandlung von Entzündungserkrankungen.
ATE311853T1 (de) Verwendung von krillenzymen zur behandlung von zahnbelag
DE3870508D1 (de) Zusammensetzung zur behandlung des haares.
DE60114002D1 (de) VERFAHREN ZUR HERSTELLUNG KRISTALLINEr PARTIKEL ZUR INHALATION
ATE190352T1 (de) Dorsalgewebe beeinflussender faktor und zusammensetzungen
HUT43106A (en) Dns sequences koding proteins of flesh-i type inhibitor activity and process for producing these proteins
DE69735583D1 (de) Semisynthetisches verfahren zur herstellung von didemninanalogen
DE3778089D1 (de) Verfahren zur herstellung und verwendung fester, pflanzenwirksamer zusammensetzungen.
HU9902668D0 (en) Compounds with growth hormone releasing properties
ATE107859T1 (de) Verwendung von antiprogestomimetika zur stimulierung des eisprungs.
DE68911132D1 (de) Hematopoietische kolonien stimulierende faktoren zur verbesserung des lipoprotein/cholesterin-profils.
DK0674714T3 (da) Rekombinant gastrisk lipase fra hunde og farmaceutiske sammensætninger
DE69531554D1 (de) Verwendung von inosittriphosphat zur herstellung von arzneimitteln
DE69835828D1 (de) Muc-1 derivate und deren verwendung zur behandlung von krebsassoziierter muc-1 mucin induzierter immunosuppression
DE59102565D1 (de) Verfahren zur Herstellung ionenleitender Keramik.
IS5613A (is) Notkun CD137 til að stuðla að fjölgun jaðar-einkjörnunga
AU7079300A (en) Compositions and methods for the treatment of immune related diseases
ATE96150T1 (de) Thioester und dessen verwendung zur herstellung von pharmazeutischen zusammensetzungen zur behandlung von ischaemie und von reperfusionsyndromen.
MY134493A (en) Thrombopoietin peptides, fragments, nucleic acids encoding the same, and method
JPS56154456A (en) S-alkyl-3-alkylthiopropionothioates, nanufacture and medicine

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0809437

Country of ref document: EP

REN Ceased due to non-payment of the annual fee